Immunotherapy for kidney cancer Doctors Abroad — Page 2

Associate Professor Hasan Mutlu leads the medical oncology department at Medical Park Antalya, specialising in next-generation genetic research and immunotherapy for organ tumours.

• Trained at Hacettepe University – one of Turkey's highest-ranking medical schools
• Awarded Associate Professorship for his work at Akdeniz University Department of Oncology
• Expert in targeted cancer therapies and complementary medicine protocols
• Specialises in using genetic research to guide personalised immunotherapy plans
• Extensive background in both internal medicine and medical oncology

The doctor is an oncologist specializing in the treatment of breast, lung, and gastrointestinal cancers. Currently, the doctor practices at Istinye Liv University Hospital.

With a career spanning multiple esteemed institutions, the doctor has served as an Internal Medicine Specialist at Malatya State Hospital, a physician at Ankara Oncology Clinic, and a member of the Oncology Department at Erzurum Regional Training and Research Hospital.

The doctor graduated from the Faculty of Medicine at Selcuk University and achieved the title of Associate Professor in 2016.

Professor Ercan Ozden serves as a medical oncology specialist at VM Medical Park Pendik Hospital, specialising in internal medicine and complex cancer therapies.

• Completed an English Medical Programme at Istanbul University Cerrahpasa Faculty of Medicine
• Broad residency training in internal medicine at a leading Turkish university hospital
• Highly specialised subspecialty training in medical oncology from Kocaeli University
• Works within the JCI-accredited Medical Park network providing evidence-based protocols

Associate Professor Muhammed Mustafa Atci is a leading medical oncologist at İstinye University Liv Hospital Topkapı with a prolific research background in advanced cancer markers.

• Member of the American Society of Clinical Oncology (ASCO) since 2018
• Serves as the Education Coordinator for the Medical Oncology Sub-Branch
• Published 19 peer-reviewed studies on biomarkers and treatment survival outcomes
• Specialises in managing complex metastatic cases using evidence-based protocols
• Expertise in interpreting molecular and genomic profiles to guide therapy choices

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Dr. Tuncay Tas is a urological surgeon at Safe Urology Clinic in Istanbul. He is among the first five experts globally to publish data on P-Shot applications. Dr. Tas specializes in urological oncology and male sexual health. He completed a fellowship in laparoscopic urology at Heidelberg University, Germany.

• Pioneered combined PRP and stem cell penile therapy in Turkey.
• Developed a certified surgical technique for penile circumference improvement.
• Performs robotic prostatectomies and kidney-sparing surgeries for cancer treatment.
• Serves as an instructor for the International Society for Stem Cells Applications.

Associate Professor Atakan Topcu is a leading medical oncologist at Medipol Acıbadem Regional Hospital with a specialist focus on immunotherapy and targeted therapies for solid tumours.

• Serves on the Editorial Board for BMC Cancer, a respected international medical journal
• Published over 50 scientific articles on advanced cancer treatments and patient outcomes
• Full member of the European Society for Medical Oncology (ESMO)
• Completed a clinical observership at the University of Leicester in the United Kingdom
• Specialises in managing cancer-related malnutrition and cachexia alongside oncology treatments

Associate Professor Ayse Irem Yasin holds an ESMO Board Certificate from Paris, a prestigious recognition of expertise in modern cancer protocols. She currently treats oncology patients at Medipol Acıbadem District Hospital.

• Specialises in urological cancers, including complex kidney cancer cases
• Completed clinical observerships at the Cleveland Clinic and Harvard Medical School
• Expert in managing adenocarcinomas using precision systemic therapies
• Focuses on the latest immunotherapy applications for various solid tumours

Associate Professor Nail Paksoy is an ESMO-certified medical oncologist specialising in complex cancer care and advanced immunotherapy protocols.

• Completed a dedicated fellowship in Allergy and Immunology, providing deep expertise in how the immune system interacts with cancer treatments
• Published specific research on outcomes for metastatic renal cell carcinoma and urothelial tumours
• Served as a sub-investigator for major international clinical trials with Roche, Pfizer, and AstraZeneca
• Holds ESMO Board Certification in Medical Oncology, an internationally recognised standard of excellence

Associate Professor Abdullah Sakin is a leading medical oncologist at Medipol Bahçelievler University Hospital who specialises in systemic therapies for solid tumours.

• Expert in immunotherapy protocols using specific agents like Pembrolizumab
• Former Head of Medical Oncology at Yüzüncü Yıl University Faculty of Medicine
• Uses molecular targeted biological therapies to treat advanced-stage malignancies
• Served as Education Officer at Prof Dr Cemil Taşçıoğlu City Hospital
• Specialises in combined treatment plans including targeted therapy and chemotherapy

The doctor is an experienced nuclear medicine specialist at HCG Manavata Cancer Centre with 12 years in the field. The doctor specializes in various nuclear scans, PET-CT scans, and nuclear cardiology services, demonstrating proficiency in radioiodine and Lu-177 RN therapies. Over the course of their career, the doctor has managed more than 30,000 PET scans and treated over 1,000 thyroid cancer patients. Additionally, the doctor has contributed to the field through published papers in various medical journals.

Prof. Dr. Abdullah Sakin is a professor of medical oncology. He treats solid tumors, including lung, breast, gastrointestinal, genitourinary, gynecologic, head and neck cancers, and melanoma.

He delivers personalized, evidence-based care. His treatments include chemotherapy, targeted therapy, immunotherapy, hormone therapy, and precision oncology. He has authored more than 200 scientific publications and takes part in international clinical research. This work advances patient-centered cancer care.

The doctor graduated with a Bachelor of Medicine from Mysore University in 1996, followed by a Doctor of Medicine in radiotherapy from Banaras Hindu University in 2002. Further enhancing expertise, the doctor earned a Diplomate of National Board in radiotherapy in 2004.

The doctor is a member of several prestigious organizations, including the Association of Radiation Oncology of India, the Society for Neuro-Oncology, the Bangalore Oncology Group, and the Indian Association of Hyperthermia Oncology, reflecting a strong commitment to advancing the field of oncology.